Ayako Ojima

936 total citations
18 papers, 771 citations indexed

About

Ayako Ojima is a scholar working on Clinical Biochemistry, Endocrinology, Diabetes and Metabolism and Molecular Biology. According to data from OpenAlex, Ayako Ojima has authored 18 papers receiving a total of 771 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Clinical Biochemistry, 7 papers in Endocrinology, Diabetes and Metabolism and 6 papers in Molecular Biology. Recurrent topics in Ayako Ojima's work include Advanced Glycation End Products research (13 papers), Chronic Kidney Disease and Diabetes (4 papers) and Diabetes Treatment and Management (4 papers). Ayako Ojima is often cited by papers focused on Advanced Glycation End Products research (13 papers), Chronic Kidney Disease and Diabetes (4 papers) and Diabetes Treatment and Management (4 papers). Ayako Ojima collaborates with scholars based in Japan and United States. Ayako Ojima's co-authors include Takanori Matsui, Sho‐ichi Yamagishi, Nobutaka Nakamura, Sayaka Maeda, Yoshinori Nishino, Masayoshi Takeuchi, Yuri Nishino, Kei Fukami, Yuji Ishibashi and Yuichiro Higashimoto and has published in prestigious journals such as Journal of Neurochemistry, American Journal Of Pathology and Laboratory Investigation.

In The Last Decade

Ayako Ojima

18 papers receiving 761 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ayako Ojima Japan 15 401 271 241 138 104 18 771
Nobutaka Nakamura Japan 14 398 1.0× 363 1.3× 197 0.8× 153 1.1× 155 1.5× 19 862
Yuri Nishino Japan 16 441 1.1× 343 1.3× 202 0.8× 131 0.9× 162 1.6× 28 912
Felicia Y. T. Yap Australia 12 495 1.2× 369 1.4× 209 0.9× 266 1.9× 135 1.3× 15 1.0k
Motofumi Sasaki Japan 13 334 0.8× 104 0.4× 202 0.8× 177 1.3× 177 1.7× 16 781
David Barit Australia 8 245 0.6× 404 1.5× 264 1.1× 90 0.7× 234 2.3× 11 974
Hiromi Fujishima Japan 12 389 1.0× 152 0.6× 260 1.1× 206 1.5× 258 2.5× 12 1.0k
Christine Koulis Australia 11 155 0.4× 188 0.7× 223 0.9× 102 0.7× 40 0.4× 13 863
Andrea Hodgkinson United Kingdom 15 121 0.3× 144 0.5× 264 1.1× 55 0.4× 85 0.8× 28 702
Kohachiro Koga Japan 9 292 0.7× 571 2.1× 217 0.9× 48 0.3× 174 1.7× 11 943
Lydia Sturgis United States 5 162 0.4× 219 0.8× 315 1.3× 112 0.8× 32 0.3× 6 738

Countries citing papers authored by Ayako Ojima

Since Specialization
Citations

This map shows the geographic impact of Ayako Ojima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ayako Ojima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ayako Ojima more than expected).

Fields of papers citing papers by Ayako Ojima

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ayako Ojima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ayako Ojima. The network helps show where Ayako Ojima may publish in the future.

Co-authorship network of co-authors of Ayako Ojima

This figure shows the co-authorship network connecting the top 25 collaborators of Ayako Ojima. A scholar is included among the top collaborators of Ayako Ojima based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ayako Ojima. Ayako Ojima is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Matsui, Takanori, Nobutaka Nakamura, Ayako Ojima, Yoshinori Nishino, & Sho‐ichi Yamagishi. (2016). Sulforaphane reduces advanced glycation end products (AGEs)-induced inflammation in endothelial cells and rat aorta. Nutrition Metabolism and Cardiovascular Diseases. 26(9). 797–807. 60 indexed citations
2.
Matsui, Takanori, Yuri Nishino, Ayako Ojima, et al.. (2015). Dipeptidyl peptidase-4 deficiency protects against experimental diabetic nephropathy partly by blocking the advanced glycation end products-receptor axis. Laboratory Investigation. 95(5). 525–533. 45 indexed citations
3.
Maeda, Satoshi, Takanori Matsui, Ayako Ojima, et al.. (2015). DNA Aptamer Raised against Advanced Glycation End Products Prevents Abnormalities in Electroretinograms of Experimental Diabetic Retinopathy. Ophthalmic Research. 54(4). 175–180. 14 indexed citations
4.
Matsui, Takanori, Ayako Ojima, Yuichiro Higashimoto, et al.. (2015). Pigment epithelium-derived factor inhibits caveolin-induced interleukin-8 gene expression and proliferation of human prostate cancer cells. Oncology Letters. 10(4). 2644–2648. 7 indexed citations
5.
Ojima, Ayako, Takanori Matsui, Yoshinori Nishino, Nobutaka Nakamura, & Sho‐ichi Yamagishi. (2015). Empagliflozin, an Inhibitor of Sodium-Glucose Cotransporter 2 Exerts Anti-Inflammatory and Antifibrotic Effects on Experimental Diabetic Nephropathy Partly by Suppressing AGEs-Receptor Axis. Hormone and Metabolic Research. 47(9). 686–692. 183 indexed citations
6.
7.
Ojima, Ayako, Takanori Matsui, Sayaka Maeda, et al.. (2014). DNA aptamer raised against advanced glycation end products inhibits melanoma growth in nude mice. Laboratory Investigation. 94(4). 422–429. 37 indexed citations
8.
Matsui, Takanori, Yuri Nishino, Ayako Ojima, et al.. (2014). Pigment Epithelium–Derived Factor Improves Metabolic Derangements and Ameliorates Dysregulation of Adipocytokines in Obese Type 2 Diabetic Rats. American Journal Of Pathology. 184(4). 1094–1103. 23 indexed citations
9.
Ojima, Ayako, et al.. (2014). DNA aptamer raised against advanced glycation end products inhibits neointimal hyperplasia in balloon-injured rat carotid arteries. International Journal of Cardiology. 171(3). 443–446. 15 indexed citations
10.
Maeda, Sayaka, Takanori Matsui, Ayako Ojima, Masayoshi Takeuchi, & Sho‐ichi Yamagishi. (2014). Sulforaphane inhibits advanced glycation end product–induced pericyte damage by reducing expression of receptor for advanced glycation end products. Nutrition Research. 34(9). 807–813. 35 indexed citations
11.
Kan, Hiromi, Sho‐ichi Yamagishi, Ayako Ojima, et al.. (2014). Elevation of Serum Levels of Advanced Glycation End Products in Patients With Non‐B or Non‐C Hepatocellular Carcinoma. Journal of Clinical Laboratory Analysis. 29(6). 480–484. 28 indexed citations
12.
Ojima, Ayako, Takanori Matsui, Nobutaka Nakamura, et al.. (2014). DNA Aptamer Raised Against Advanced Glycation End Products (AGEs) Improves Glycemic Control and Decreases Adipocyte Size in Fructose-Fed Rats by Suppressing AGE-RAGE Axis. Hormone and Metabolic Research. 47(4). 253–258. 21 indexed citations
13.
Maeda, Satoshi, Sho‐ichi Yamagishi, Takanori Matsui, et al.. (2013). Beneficial Effects of Vildagliptin on Retinal Injury in Obese Type 2 Diabetic Rats. Ophthalmic Research. 50(4). 221–226. 27 indexed citations
14.
15.
Ishibashi, Yuji, Takanori Matsui, Ayako Ojima, et al.. (2012). Glucagon-like peptide-1 inhibits angiotensin II-induced mesangial cell damage via protein kinase A. Microvascular Research. 84(3). 395–398. 42 indexed citations
16.
Ojima, Ayako, Takanori Matsui, Sayaka Maeda, Masayoshi Takeuchi, & Sho‐ichi Yamagishi. (2012). Glucose-dependent Insulinotropic Polypeptide (GIP) Inhibits Signaling Pathways of Advanced Glycation End Products (AGEs) in Endothelial Cells via its Antioxidative Properties. Hormone and Metabolic Research. 44(7). 501–505. 45 indexed citations
17.
Ojima, Ayako, Yasuhito Nakagawa, Takayuki Sugiura, Yasuo Masuzawa, & Keizo Waku. (1987). Selective Transacylation of 1‐O‐Alkylglycerophosphoethanolamine by Docosahexaenoate and Arachidonate in Rat Brain Microsomes. Journal of Neurochemistry. 48(5). 1403–1410. 33 indexed citations
18.
Masuzawa, Yasuo, et al.. (1986). Selective acylation of alkyllysophospholipids by docosahexaenoic acid in Ehrlich ascites cells. Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism. 876(1). 80–90. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nobutaka Nakamura Breakdown of academic impact, for papers by Yuri Nishino Breakdown of academic impact, for papers by Felicia Y. T. Yap Breakdown of academic impact, for papers by Motofumi Sasaki Breakdown of academic impact, for papers by David Barit Breakdown of academic impact, for papers by Hiromi Fujishima Breakdown of academic impact, for papers by Christine Koulis Breakdown of academic impact, for papers by Andrea Hodgkinson Breakdown of academic impact, for papers by Kohachiro Koga Breakdown of academic impact, for papers by Lydia Sturgis
Rankless by CCL
2026